Annual General Meeting And Book Closure Notice
This is to inform you that the Annual General Meeting of the Company is scheduled to be held on Thursday, September 6, 2018 at 3:00 p.m. at Rama Watumull Auditorium,Kishinchand Chellaram College, 124, Dinshaw Wachha Road, Churchgate, Mumbai 400020. We hereby enclose a copy of the Annual Report of the Company for the Financial Year ended March 31, 2018 for your reference.... Viagra: Pfizer set to lose patent-protected monopoly in US; 7 Indian firms readying clones
When the Indian firms start selling the pill in the US, prices are expected to fall by a staggering 99 percent. While each pill of Viagra costs $65 (Rs 4,450) in the US, its Indian clones sell for as little as Rs 32 per tablet in India.
Pfizer Q1 profit rises 61% to 92 crore
Pfizer's standalone revenue from operations stood at 512.31 crore for the April-June quarter of the current fiscal Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find enclosed press release for the financial results for the quarter ended June 30, 2018. Unaudited Financial Results For The Quarter Ended June 30, 2018.
Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith the unaudited financial results for the quarter ended June 30, 2018, which were approved by the Board of Directors of the Company at its Meeting held today, that commenced at 11:30 a.m. and concluded at 1:00 p.m.... Board Meeting Intimation for Board Meeting For The Unaudited Financial Results For The Quarter Ended June 30, 2018 And Intimation Of Closure Of Trading Window.
PFIZER LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/08/2018 ,inter alias, to consider and approve This is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Thursday, August 2, 2018, inter alia, to consider and take on record the Unaudited Financial Results of the Company for the quarter ended June 30, 2018.... Pfizer Ltd reply to clarification sought by the exchange
The Exchange had sought clarification from Pfizer Ltd with respect to news article appearing on www.business-standard.com - July 12, 2018 "Pfizer's Tamil Nadu injectable plant gets 11 USFDA observations" Pfizer Ltd response is enclosed. Clarification sought from Pfizer Ltd
The Exchange has sought clarification from Pfizer Ltd with respect to news article appearing on www.business-standard.com - July 12, 2018 titled "Pfizer's Tamil Nadu injectable plant gets 11 USFDA observations". The reply is awaited. Pfizer stops production at Tamil Nadu plant after 11 USFDA observations
Firm says it is disappointed with the outcome of the inspection Statement Of Investor Complaints For The Quarter Ended June 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 218191 Name of the Signatory :- PRAJEET NAIRDesignation :- Company Secretary and Compliance Officer